Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Melanoma treatment: from conventional to nanotechnology
Harshita Mishra, Pawan Kumar Mishra, Adam Ekielski, et al.
Journal of Cancer Research and Clinical Oncology (2018) Vol. 144, Iss. 12, pp. 2283-2302
Closed Access | Times Cited: 154

Showing 1-25 of 154 citing articles:

Experimental Evidence of the Antitumor, Antimetastatic and Antiangiogenic Activity of Ellagic Acid
Claudia Ceci, Pedro Miguel Lacal, Lucio Tentori, et al.
Nutrients (2018) Vol. 10, Iss. 11, pp. 1756-1756
Open Access | Times Cited: 214
Highly Efficient In Vivo Cancer Therapy by an Implantable Magnet Triboelectric Nanogenerator
Chaochao Zhao, Hongqing Feng, Lijun Zhang, et al.
Advanced Functional Materials (2019) Vol. 29, Iss. 41
Closed Access | Times Cited: 121
Oxidative stress and antioxidants in the pathophysiology of malignant melanoma
Elena Obrador, Feng Liu, Ryan W. Dellinger, et al.
Biological Chemistry (2018) Vol. 400, Iss. 5, pp. 589-612
Open Access | Times Cited: 105
Hybrid Hydrogel Composed of Carboxymethylcellulose–Silver Nanoparticles–Doxorubicin for Anticancer and Antibacterial Therapies against Melanoma Skin Cancer Cells
Nádia S. V. Capanema, Isadora C. Carvalho, Alexandra A.P. Mansur, et al.
ACS Applied Nano Materials (2019) Vol. 2, Iss. 11, pp. 7393-7408
Closed Access | Times Cited: 101
Parthenolide as Cooperating Agent for Anti-Cancer Treatment of Various Malignancies
Małgorzata Sztiller-Sikorska, Małgorzata Czyż
Pharmaceuticals (2020) Vol. 13, Iss. 8, pp. 194-194
Open Access | Times Cited: 84
Green synthesis of PEG-coated MIL-100(Fe) for controlled release of dacarbazine and its anticancer potential against human melanoma cells
Mahdi Barjasteh, Manouchehr Vossoughi, Mojtaba Bagherzadeh, et al.
International Journal of Pharmaceutics (2022) Vol. 618, pp. 121647-121647
Closed Access | Times Cited: 49
DDTC-Cu(I) based metal-organic framework (MOF) for targeted melanoma therapy by inducing SLC7A11/GPX4-mediated ferroptosis
Chan Li, Sheng Zhou, Chuncheng Chen, et al.
Colloids and Surfaces B Biointerfaces (2023) Vol. 225, pp. 113253-113253
Closed Access | Times Cited: 25
Nanotechnology as a Promising Method in the Treatment of Skin Cancer
Angelika A. Adamus-Grabicka, Paweł Hikisz, Joanna Sikora
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 4, pp. 2165-2165
Open Access | Times Cited: 13
On‐Site Melanoma Diagnosis Utilizing a Swellable Microneedle‐Assisted Skin Interstitial Fluid Sampling and a Microfluidic Particle Dam for Visual Quantification of S100A1
Gaobo Wang, Yuyue Zhang, Hoi Kwan Kwong, et al.
Advanced Science (2024) Vol. 11, Iss. 16
Open Access | Times Cited: 10
WT161, a selective HDAC6 inhibitor, decreases growth, enhances chemosensitivity, promotes apoptosis, and suppresses motility of melanoma cells
João Marcos Oliveira‐Silva, Leilane Sales Oliveira, Carolina Berraut Chiminazo, et al.
Cancer Chemotherapy and Pharmacology (2025) Vol. 95, Iss. 1
Closed Access | Times Cited: 1
Harnessing Peptide-based Nanotherapeutics: Pioneering Melanoma Management from Diagnosis to Theranostics
Shalini Shukla, Pooja Khairnar, Aachal Hedaoo, et al.
Journal of Drug Delivery Science and Technology (2025), pp. 106811-106811
Closed Access | Times Cited: 1
From Conventional Therapies to Immunotherapy: Melanoma Treatment in Review
Łukasz Kuryk, Laura Bertinato, Monika Staniszewska, et al.
Cancers (2020) Vol. 12, Iss. 10, pp. 3057-3057
Open Access | Times Cited: 65
Automatic segmentation model combining U-Net and level set method for medical images
Yunyun Yang, Chong Feng, Ruofan Wang
Expert Systems with Applications (2020) Vol. 153, pp. 113419-113419
Closed Access | Times Cited: 61
LncRNA MEG3 promotes melanoma growth, metastasis and formation through modulating miR-21/E-cadherin axis
Liangcai Wu, Lifei Zhu, Yanchang Li, et al.
Cancer Cell International (2020) Vol. 20, Iss. 1
Open Access | Times Cited: 55
Dermatological applications of the flavonoid phloretin
Talita Pizza Anunciato Casarini, Luíza Abrahão Frank, Adriana Raffin Pohlmann, et al.
European Journal of Pharmacology (2020) Vol. 889, pp. 173593-173593
Closed Access | Times Cited: 51
Melanoma and Nanotechnology-Based Treatment
Hong Zeng, Jia Li, Kai Hou, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 32
PCL/gelatin nanofibers embedded with doxorubicin-loaded mesoporous silica nanoparticles/silver nanoparticles as an antibacterial and anti-melanoma cancer
Melika Tavira, Mohammad Mousavi-Khattat, Zahra Shakeran, et al.
International Journal of Pharmaceutics (2023) Vol. 642, pp. 123162-123162
Closed Access | Times Cited: 20
A comprehensive review on novel targeted therapy methods and nanotechnology-based gene delivery systems in melanoma
Azadeh Rahimi, Yasaman Esmaeili, Nasim Dana, et al.
European Journal of Pharmaceutical Sciences (2023) Vol. 187, pp. 106476-106476
Open Access | Times Cited: 18
Nanodelivery systems for cutaneous melanoma treatment
Irina Pereira, Carina Monteiro, Miguel Pereira‐Silva, et al.
European Journal of Pharmaceutics and Biopharmaceutics (2023) Vol. 184, pp. 214-247
Open Access | Times Cited: 17
Co-Delivery of Eugenol and Dacarbazine by Hyaluronic Acid-Coated Liposomes for Targeted Inhibition of Survivin in Treatment of Resistant Metastatic Melanoma
Harshita Mishra, Pawan Kumar Mishra, Zeenat Iqbal, et al.
Pharmaceutics (2019) Vol. 11, Iss. 4, pp. 163-163
Open Access | Times Cited: 48
A novel spheroid-based co-culture model mimics loss of keratinocyte differentiation, melanoma cell invasion, and drug-induced selection of ABCB5-expressing cells
Julia Klicks, Christoph Maßlo, Andreas Kluth, et al.
BMC Cancer (2019) Vol. 19, Iss. 1
Open Access | Times Cited: 44
A sulfur dioxide polymer prodrug showing combined effect with doxorubicin in combating subcutaneous and metastatic melanoma
Lin An, Peng Zhang, Wei Shen, et al.
Bioactive Materials (2020) Vol. 6, Iss. 5, pp. 1365-1374
Open Access | Times Cited: 44
Paraoxonase-2 Silencing Enhances Sensitivity of A375 Melanoma Cells to Treatment with Cisplatin
Roberto Campagna, Tiziana Bacchetti, Eleonora Salvolini, et al.
Antioxidants (2020) Vol. 9, Iss. 12, pp. 1238-1238
Open Access | Times Cited: 41
Beyond Nicotinamide Metabolism: Potential Role of Nicotinamide N-Methyltransferase as a Biomarker in Skin Cancers
Roberto Campagna, Valentina Pozzi, Davide Sartini, et al.
Cancers (2021) Vol. 13, Iss. 19, pp. 4943-4943
Open Access | Times Cited: 41
The Challenging Melanoma Landscape: From Early Drug Discovery to Clinical Approval
Mariana Matias, Jacinta O. Pinho, Maria João Penetra, et al.
Cells (2021) Vol. 10, Iss. 11, pp. 3088-3088
Open Access | Times Cited: 39
Page 1 - Next Page

Scroll to top